Pfizer, BioNTech to submit emergency use request to FDA
Photo Cred: Nataliya Vaitkevich/Pexels By Katherine Shagoury Pharmaceutical giants Pfizer and BioNTech announced today the companies would submit a request to the U.S. Food and Drug Administration (FDA) for emergency...
Read MoreCDC urges Americans to avoid Thanksgiving travel
Photo Cred: Craig Adderley/Pexels By Katherine Shagoury The U.S. Centers for Disease Control and Prevention (CDC) urged Americans in its latest guidance to avoid travel during the Thanksgiving holiday and...
Read MoreSleep apnea potential risk factor for COVID-19
Photo Cred: Andrea Piacquadio/Pexels By Katherine Shagoury Sleep apnea could be a possible risk factor for the novel coronavirus (COVID-19), according to new research published in Sleep Medicine and Disorders:...
Read MoreLasting fatigue common after COVID-19 infection, study finds
Photo Cred: Doğukan Şahin/Unsplash By Katherine Shagoury More than half of people with acute novel coronavirus (COVID-19) infection continue to have persistent fatigue 10 weeks after their initial illness, according...
Read MoreFDA authorizes first at-home COVID-19 test
Photo Cred: Mufid Majnun/Unsplash By Katherine Shagoury The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first at-home novel coronavirus (COVID-19) diagnostic test that provides rapid results,...
Read MorePfizer and BioNTech say vaccine effective, no safety concerns
Photo Cred: Fernando zhiminaicela/Pixabay By Katherine Shagoury A final efficacy analysis of the Pfizer and BioNTech novel coronavirus (COVID-19) vaccine found it is 95 percent effective in preventing infections across...
Read MoreVitamin C for COVID-19 treatment may benefit some populations
Photo Cred: Lisa Fotios/Pexels By Katherine Shagoury High doses of vitamin C for treating the novel coronavirus (COVID-19) may benefit some populations, but researchers said factors that influence effectiveness include...
Read MoreModerna COVID-19 vaccine 94.5 percent effective in major trial
Photo Cred: Gustavo Fring/Pexels By Katherine Shagoury Moderna, a biotechnology company based in Cambridge, Massachusetts, announced this morning its novel coronavirus (COVID-19) vaccination, mRNA-1273, appears to be 94.5 percent effective,...
Read More